FOLLOW US
For Professionals

Literature Review

EndoScan is an online endocrinology publication authored by physicians and endocrine-related specialists. Each issue presents and discusses a timely endocrine subject through an in depth review of the literature. EndoScan affords physicians and healthcare providers a reliable resource for current information on important endocrine topics.

Testosterone Use in Men: 2016 Update

April 2016
Volume 7, Issue 2
In this EndoScan, we review baseline and existing long-term results of the anticipated Testosterone Trials (TTrials) and Testosterone's Effects on Atherosclerosis Progression in Aging Men (TEAAM) trial, other recent research on the impact of T use on sexual function and cardiovascular risk, and options for treatment of hypogonadal men desiring fertility.

Fracture Risk in Women with Breast Cancer

January 2016
Volume 7, Issue 1
Bone health in breast cancer is an important topic given the large number of breast cancer survivors. In this issue of EndoScan, Azeez Farooki, MD reviews the topic by several studies and the incidence of osteoporotic-related fractures, bone mineral density, and bone-protecting therapies.

Management of Thyroid Nodules

July 2015
Volume 6, Issue 3
There are multiple studies that aid clinicians in the diagnosis and management of thyroid nodules. In this EndoScan, we discuss some of the newer guidelines and studies that have impacted the management of thyroid nodules.

Getting Growth Hormone Levels Just Right: The Goldilocks Principle

April 2015
Volume 6, Issue 2
Adult acquired growth hormone deficiency (GHD), requires a delicate approach to get hormone levels just right; the impact of GH replacement (GHR) extends to cardiovascular health and issues of quality of life.

Bariatric Endocrinology: 2015 Update

January 2015
Volume 6, Issue 1
Science now recognizes adipose tissue as a very active participant in metabolism, not just a place for passive storage of energy. Adiposopathy, or sick fat, plays a role in the development of metabolic diseases. There have been major developments that have advanced the medical, social, political and economic avenues to optimal medical care for people with overweight or obesity.

Menopause and the Impact of Hormone Replacement on Chronic Disease: Current Controversies and Findings

December 2014
Volume 5, Issue 4
EndoScan reviews the current thinking and controversies regarding postmenopausal hormone therapy, focusing on the impact on cardiovascular health and coronary heart disease; breast cancer; and cognition and mood. It is important to reiterate that, while symptomatic relief is not within the scope of this review, there is general agreement that HRT alleviates vasomotor symptoms, and the benefits of HRT may outweigh health risks in some patients at some times.

Male Weight and Fertility

August 2014
Volume 5, Issue 3
EndoScan reviews male weight and fertility, and research investigating an association between male weight/adiposity and sexual function, serum hormone levels, and sperm parameters.

Weight and Fertility: A Review

May 2014
Volume 5, Issue 2
In this issue of EndoScan, we review a cross-section of topics related to the impact of weight on fertility. Any of the topics covered in this issue could be the focus of its own in-depth review.

Testosterone Use in Men

March 2014
Volume 5, Issue 1
Prescriptions for testosterone supplementation in men is the subject of the March 2014 issue of EndoScan.

Sodium-Glucose Cotransporter 2 Inhibitors

October 2013
Volume 4, Issue 5
New drugs help lower glycemic index and weight in patients with diabetes

Comorbid Obesity and Diabetes

June 2013
Volume 4, Issue 4
Recent Research Sheds Light on Potential Causes of These Overlapping Problems As Well As Effective Management Strategies for Both

Diagnosis of Hypogonadism in Men

April 2013
Volume 4, Issue 2
This issue of EndoScan focuses on the different factors that are essential in correctly diagnosing testosterone deficiency in adult men. Commentary from leading hypogonadism experts follows each selected abstract.

Updates in Bariatric Endocrinology

April 2013
Volume 4, Issue 3
J. Michael Gonzalez-Campoy, MD, PhD, FACE, provides a succinct update on developments in bariatric endocrinology. Learn what's new in risk stratification, complications, and pharmacotherapy

Osteoporosis Treatment

February 2013
Volume 4, Issue 1
This edition of EndoScan reviews 2 new osteoporosis medications, as well as current guidelines for osteoporosis management. Commentary provided by Pauline M. Camacho, MD, FACE, from Loyola University.

Current Research on Graves' Ophthalmopathy

November 2012
Volume 3, Issue 4
EndoScan literature review focused on current research in Graves' ophthalmopathy. Commentary provided by thyroid expert from the Cleveland Clinic.

Depression, Distress, and Diabetes

September 2012
Volume 3, Issue 3
September 2012 issue of EndoScan from EndocrineWeb. Depression, Distress, and Diabetes: Emerging Evidence and New Directions. Expert commentary from Leonard E. Egede, MD, MS.

The Importance of Blood Pressure Control in People with Type 1 Diabetes

June 2012
Volume 3, Issue 2
Hypertension is a risk factor for both microvascular and macrovascular complications in patients with diabetes mellitus. There are few studies investigating the goal blood pressure levels in patients with type 1 diabetes, so this EndoScan has been put together on the importance of blood pressure control in type 1 diabetics.

The Benefits of GLP-1 Receptor Agonists in the Therapy of Type 2 Diabetes

December 2011
Volume 2, Issue 2
In this edition of EndoScan, we will focus on the beneficial effect of the glucagon-like peptide 1 (GLP-1) receptor agonists in the therapy of type 2 diabetes. We have chosen 3 recent studies that reported on this issue, and at the end of every abstract, a short commentary has been provided.

Contemporary Challenges in the Management of Thyroid Cancer

May 2011
Volume 2, Issue 1
In this edition of EndoScan, we will focus on the topic of thyroid cancer. We have included six abstracts that address a variety of contemporary challenges in the management of thyroid cancer patients. A commentary section follows each abstract.

Type 2 Diabetes and Glycated Hemoglobin (HbA1c)

December 2010
Volume 1, Issue 1
In this edition of EndoScan, we will focus on glycated hemoglobin (HbA1c) goals in the non-pregnant type 2 diabetic. We have included seven abstracts that address the implications of tight glycemic control, as well as the current controversy around HbA1c. Treatment to goal HbA1c is less than 7%.
SHOW MAIN MENU
SHOW SUB MENU